This site is intended for healthcare professionals

FDA approves Lyumjev (insulin lispro-aabc injection), a new rapid-acting insulin.- Eli Lilly

Read time: 1 mins
Last updated:16th Mar 2021
Published:17th Jun 2020
Condition: Diabetes Types 1 & 2
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest